msa-20230930false2023Q10000066570--12-31P3Y00000665702023-01-012023-09-3000000665702023-10-20xbrli:shares00000665702023-07-012023-09-30iso4217:USD00000665702022-07-012022-09-3000000665702022-01-012022-09-30iso4217:USDxbrli:shares00000665702023-09-3000000665702022-12-3100000665702023-01-012023-03-31xbrli:pure00000665702021-12-3100000665702022-09-300000066570us-gaap:RetainedEarningsMember2022-06-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000066570us-gaap:RetainedEarningsMember2022-07-012022-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000066570us-gaap:RetainedEarningsMember2022-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000066570us-gaap:RetainedEarningsMember2023-06-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000066570us-gaap:RetainedEarningsMember2023-07-012023-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000066570us-gaap:RetainedEarningsMember2023-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000066570us-gaap:RetainedEarningsMember2021-12-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000066570us-gaap:RetainedEarningsMember2022-01-012022-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000066570us-gaap:RetainedEarningsMember2022-12-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000066570us-gaap:RetainedEarningsMember2023-01-012023-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:CorporateNonSegmentMember2023-01-012023-09-300000066570msa:InternationalMember2022-01-012022-09-300000066570msa:AmericasSegmentMember2022-01-012022-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2021-12-310000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2021-12-310000066570us-gaap:CorporateNonSegmentMember2021-12-310000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2022-01-012022-12-310000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2022-01-012022-12-310000066570us-gaap:CorporateNonSegmentMember2022-01-012022-12-3100000665702022-01-012022-12-310000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2022-12-310000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2022-12-310000066570us-gaap:CorporateNonSegmentMember2022-12-310000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2023-09-300000066570us-gaap:CorporateNonSegmentMember2023-09-300000066570us-gaap:LandMember2023-09-300000066570us-gaap:LandMember2022-12-310000066570us-gaap:BuildingMember2023-09-300000066570us-gaap:BuildingMember2022-12-310000066570us-gaap:MachineryAndEquipmentMember2023-09-300000066570us-gaap:MachineryAndEquipmentMember2022-12-310000066570us-gaap:ConstructionInProgressMember2023-09-300000066570us-gaap:ConstructionInProgressMember2022-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-07-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-07-012022-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-01-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-01-012022-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-07-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-07-012022-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-01-012022-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000066570us-gaap:CumulativePreferredStockMember2023-09-300000066570us-gaap:CumulativePreferredStockMember2023-01-012023-09-300000066570us-gaap:PreferredStockMember2023-09-300000066570msa:SecondCumulativePreferredVotingStockMember2023-09-300000066570us-gaap:CommonStockMember2022-12-310000066570us-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:CommonStockMember2022-01-012022-09-300000066570us-gaap:CommonStockMember2023-09-300000066570us-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:TreasuryStockCommonMember2022-01-012022-09-300000066570us-gaap:CommonStockMember2023-06-300000066570us-gaap:TreasuryStockCommonMember2023-06-300000066570us-gaap:CommonStockMember2022-06-300000066570us-gaap:TreasuryStockCommonMember2022-06-300000066570us-gaap:CommonStockMember2023-07-012023-09-300000066570us-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570us-gaap:CommonStockMember2022-07-012022-09-300000066570us-gaap:TreasuryStockCommonMember2022-07-012022-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2022-07-012022-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2022-07-012022-09-300000066570us-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2023-07-012023-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570us-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2022-07-012022-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2022-07-012022-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2022-07-012022-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2022-07-012022-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2022-07-012022-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2022-07-012022-09-300000066570us-gaap:CommonStockMember2023-09-300000066570us-gaap:TreasuryStockCommonMember2023-09-300000066570us-gaap:CommonStockMember2022-09-300000066570us-gaap:TreasuryStockCommonMember2022-09-300000066570us-gaap:CommonStockMember2022-12-310000066570us-gaap:TreasuryStockCommonMember2022-12-310000066570us-gaap:CommonStockMember2021-12-310000066570us-gaap:TreasuryStockCommonMember2021-12-310000066570us-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:CommonStockMember2022-01-012022-09-300000066570us-gaap:TreasuryStockCommonMember2022-01-012022-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2022-01-012022-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2022-01-012022-09-300000066570us-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2023-01-012023-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:CommonStockMemberus-gaap:EmployeeStockOptionMember2022-01-012022-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2022-01-012022-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2022-01-012022-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2022-01-012022-09-300000066570us-gaap:CommonStockMembermsa:EmployeeStockPurchasePlanMember2023-01-012023-09-300000066570us-gaap:TreasuryStockCommonMembermsa:EmployeeStockPurchasePlanMember2023-01-012023-09-300000066570us-gaap:CommonStockMembermsa:EmployeeStockPurchasePlanMember2022-01-012022-09-300000066570us-gaap:TreasuryStockCommonMembermsa:EmployeeStockPurchasePlanMember2022-01-012022-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2022-01-012022-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2022-01-012022-09-30msa:Segment0000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2023-07-012023-09-300000066570us-gaap:CorporateNonSegmentMember2023-07-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2022-07-012022-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2022-07-012022-09-300000066570us-gaap:CorporateNonSegmentMember2022-07-012022-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2023-01-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2022-01-012022-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2022-01-012022-09-300000066570us-gaap:CorporateNonSegmentMember2022-01-012022-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:BreathingApparatusMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570msa:AmericasSegmentMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570msa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570msa:PortableInstrumentsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:PortableInstrumentsMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:HeadProtectionMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:HeadProtectionMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:HeadProtectionMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:FallProtectionMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2023-07-012023-09-300000066570msa:AmericasSegmentMembermsa:FallProtectionMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2023-07-012023-09-300000066570msa:InternationalMembermsa:FallProtectionMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FallProtectionMember2023-07-012023-09-300000066570msa:OtherProductsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:AmericasSegmentMembermsa:OtherProductsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:OtherProductsMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-07-012022-09-300000066570msa:BreathingApparatusMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-07-012022-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-07-012022-09-300000066570msa:AmericasSegmentMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-07-012022-09-300000066570msa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-07-012022-09-300000066570msa:PortableInstrumentsMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:PortableInstrumentsMembermsa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-07-012022-09-300000066570msa:HeadProtectionMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:HeadProtectionMembermsa:AmericasSegmentMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:HeadProtectionMembermsa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-07-012022-09-300000066570msa:FallProtectionMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2022-07-012022-09-300000066570msa:AmericasSegmentMembermsa:FallProtectionMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2022-07-012022-09-300000066570msa:InternationalMembermsa:FallProtectionMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FallProtectionMember2022-07-012022-09-300000066570msa:OtherProductsMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:AmericasSegmentMembermsa:OtherProductsMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:OtherProductsMembermsa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:AmericasSegmentMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300000066570msa:InternationalMember2022-07-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-07-012022-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:BreathingApparatusMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570msa:AmericasSegmentMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570msa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570msa:PortableInstrumentsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:PortableInstrumentsMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:HeadProtectionMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:HeadProtectionMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:HeadProtectionMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:FallProtectionMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2023-01-012023-09-300000066570msa:AmericasSegmentMembermsa:FallProtectionMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2023-01-012023-09-300000066570msa:InternationalMembermsa:FallProtectionMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FallProtectionMember2023-01-012023-09-300000066570msa:OtherProductsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:AmericasSegmentMembermsa:OtherProductsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:OtherProductsMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-01-012022-09-300000066570msa:BreathingApparatusMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-01-012022-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-09-300000066570msa:AmericasSegmentMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-09-300000066570msa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FirefighterHelmetsandProtectiveApparelMember2022-01-012022-09-300000066570msa:PortableInstrumentsMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:AmericasSegmentMembermsa:PortableInstrumentsMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:PortableInstrumentsMembermsa:InternationalMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:PortableInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-01-012022-09-300000066570msa:HeadProtectionMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:HeadProtectionMembermsa:AmericasSegmentMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:HeadProtectionMembermsa:InternationalMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:HeadProtectionMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-01-012022-09-300000066570msa:FallProtectionMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2022-01-012022-09-300000066570msa:AmericasSegmentMembermsa:FallProtectionMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMembermsa:FallProtectionMember2022-01-012022-09-300000066570msa:InternationalMembermsa:FallProtectionMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMembermsa:FallProtectionMember2022-01-012022-09-300000066570msa:OtherProductsMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:AmericasSegmentMembermsa:OtherProductsMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570msa:OtherProductsMembermsa:InternationalMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:OtherProductsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:AmericasSegmentMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2022-01-012022-09-300000066570msa:DeferredTaxAssetMember2023-09-300000066570us-gaap:RestrictedStockMember2022-12-310000066570us-gaap:RestrictedStockMember2023-01-012023-09-300000066570us-gaap:RestrictedStockMember2023-09-300000066570srt:MinimumMember2023-01-012023-09-300000066570srt:MaximumMember2023-01-012023-09-300000066570us-gaap:PerformanceSharesMembermsa:MonteCarloApproachMember2023-01-012023-09-300000066570us-gaap:PerformanceSharesMember2023-01-012023-09-300000066570us-gaap:PerformanceSharesMember2022-12-310000066570us-gaap:PerformanceSharesMember2023-09-300000066570msa:SeniorNotesPayableThroughTwoThousandThirtyOneThreePointFourPercentageMemberMember2023-09-300000066570msa:SeniorNotesPayableThroughTwoThousandThirtyOneThreePointFourPercentageMemberMember2022-12-310000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMember2023-09-300000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMember2022-12-310000066570msa:NYLNoteFacilitySeriesASeniorNotesMember2023-09-300000066570msa:NYLNoteFacilitySeriesASeniorNotesMember2022-12-310000066570us-gaap:SecuredDebtMembermsa:TermLoanFacility2023Memberus-gaap:LineOfCreditMember2023-09-300000066570us-gaap:SecuredDebtMembermsa:TermLoanFacility2023Memberus-gaap:LineOfCreditMember2022-12-310000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2023-09-300000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2022-12-3100000665702021-05-240000066570us-gaap:BaseRateMembermsa:SeniorRevolvingCreditFacilityMaturingIn2026Member2021-05-242021-05-240000066570msa:FederalFundsOpenRateMembermsa:SeniorRevolvingCreditFacilityMaturingIn2026Member2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membermsa:OvernightBankFundingRateMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membermsa:LondonInterbankOfferedRateLIBOR1Member2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membersrt:MinimumMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membersrt:MaximumMember2021-05-242021-05-240000066570us-gaap:SeniorNotesMembermsa:MultiCurrencyNoteSeriesCSeniorNotesMember2021-07-010000066570us-gaap:UnsecuredDebtMembermsa:MultiCurrencyNoteSeriesCSeniorNotesMember2021-07-010000066570msa:MulticurrencyNotesDuein2031Memberus-gaap:NotesPayableOtherPayablesMember2023-09-30iso4217:GBP0000066570msa:MulticurrencyNotesDuein2031Memberus-gaap:NotesPayableOtherPayablesMember2023-01-012023-09-300000066570msa:NYLNoteFacilitySeriesASeniorNotesMemberus-gaap:SeniorNotesMember2021-07-010000066570msa:NYLNoteFacilitySeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2021-07-010000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2023-06-290000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2023-06-292023-06-2900000665702019-01-042019-01-040000066570us-gaap:SecuredDebtMembermsa:TermLoanFacility2023Memberus-gaap:LineOfCreditMember2023-01-050000066570us-gaap:SecuredDebtMembermsa:TermLoanFacility2023Membersrt:MinimumMemberus-gaap:LineOfCreditMember2023-01-052023-01-050000066570us-gaap:SecuredDebtMembersrt:MaximumMembermsa:TermLoanFacility2023Memberus-gaap:LineOfCreditMember2023-01-052023-01-050000066570us-gaap:StandbyLettersOfCreditMember2023-09-300000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Memberus-gaap:StandbyLettersOfCreditMember2023-09-300000066570msa:AmericasSegmentMember2023-09-300000066570msa:InternationalSegmentMember2023-09-300000066570msa:GlobeHoldingCompanyLLCMemberus-gaap:TradeNamesMember2023-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012022-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-09-300000066570us-gaap:ForeignExchangeForwardMember2023-09-300000066570us-gaap:ForeignExchangeForwardMember2022-12-310000066570us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-09-300000066570us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-12-310000066570us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2023-09-300000066570us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2022-12-310000066570us-gaap:NondesignatedMember2023-01-012023-09-300000066570us-gaap:NondesignatedMember2022-01-012022-09-3000000665702023-04-012023-06-300000066570us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-09-300000066570us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000066570us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-09-300000066570us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000066570msa:SingleIncidentMember2023-09-300000066570msa:SingleIncidentMember2022-12-310000066570msa:SingleIncidentMember2023-01-012023-09-300000066570msa:CumulativeTraumaMember2022-12-310000066570msa:ClaimsSettledButNotYetPaidMember2022-12-310000066570msa:CumulativeTraumaMemberus-gaap:OtherCurrentLiabilitiesMember2022-12-310000066570us-gaap:OtherNoncurrentLiabilitiesMembermsa:CumulativeTraumaMember2022-12-310000066570msa:MSALLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-052023-01-050000066570msa:JointVentureByRQInsuranceHoldingsLtdAndObraCapitalIncMembermsa:MSALLCMember2023-01-052023-01-050000066570msa:MSALLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-07-012023-09-300000066570msa:MSALLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-09-300000066570msa:MSALLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-06-300000066570msa:DamagesFromProductSubstancesMemberus-gaap:SubsequentEventMember2023-10-10msa:lawsuitmsa:claimmsa:class_action
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File No. 1-15579
MSA SAFETY INCORPORATED
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | |
Pennsylvania | | 46-4914539 |
(State or other jurisdiction of incorporation or organization) | | (IRS Employer Identification No.) |
| | |
1000 Cranberry Woods Drive | | |
Cranberry Township, | Pennsylvania | | 16066-5207 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (724) 776-8600
Former name or former address, if changed since last report: N/A
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | | | | | | | | | | |
Large Accelerated Filer | x | Accelerated filer | ¨ | Non-accelerated filer | ¨ | Smaller reporting company | ☐ |
| | | | | | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which is registered |
Common Stock, no par value | MSA | New York Stock Exchange |
As of October 20, 2023, 39,311,193 shares of common stock, of the registrant were outstanding.
| | | | | | | | |
Item No. | | Page |
Part I | | |
1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
2. | | |
3. | | |
4. | | |
Part II | | |
2. | | |
6. | | |
| | |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
(In thousands, except per share values) | 2023 | | 2022 | | 2023 | | 2022 |
Net sales | $ | 446,728 | | | $ | 381,694 | | | $ | 1,292,290 | | | $ | 1,084,699 | |
Cost of products sold | 227,967 | | | 212,299 | | | 678,335 | | | 608,120 | |
Gross profit | 218,761 | | | 169,395 | | | 613,955 | | | 476,579 | |
| | | | | | | |
Selling, general and administrative | 102,175 | | | 82,753 | | | 289,602 | | | 247,378 | |
Research and development | 17,682 | | | 14,416 | | | 48,906 | | | 43,017 | |
Restructuring charges (Note 3) | 3,285 | | | 899 | | | 8,382 | | | 3,146 | |
Currency exchange losses, net | 1,496 | | | 2,979 | | | 8,781 | | | 4,788 | |
Loss on divestiture of MSA LLC (Note 17) | — | | | — | | | 129,211 | | | — | |
Product liability expense (Note 17) | — | | | 4,035 | | | 3 | | | 9,733 | |
Operating income | 94,123 | | | 64,313 | | | 129,070 | | | 168,517 | |
| | | | | | | |
Interest expense | 12,498 | | | 5,962 | | | 37,149 | | | 14,158 | |
| | | | | | | |
Other income, net | (6,037) | | | (2,359) | | | (15,487) | | | (15,121) | |
Total other expense (income), net | 6,461 | | | 3,603 | | | 21,662 | | | (963) | |
| | | | | | | |
Income before income taxes | 87,662 | | | 60,710 | | | 107,408 | | | 169,480 | |
Provision for income taxes (Note 10) | 22,406 | | | 15,804 | | | 125,235 | | | 41,339 | |
Net income (loss) | $ | 65,256 | | | $ | 44,906 | | | $ | (17,827) | | | $ | 128,141 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Earnings (loss) per share attributable to common shareholders (Note 9): | | | | | | | |
Basic | $ | 1.66 | | | $ | 1.15 | | | $ | (0.46) | | | $ | 3.26 | |
Diluted | $ | 1.65 | | | $ | 1.14 | | | $ | (0.46) | | | $ | 3.25 | |
Dividends per common share | $ | 0.47 | | | $ | 0.46 | | | $ | 1.40 | | | $ | 1.36 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Unaudited
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
(In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
Net income (loss) | $ | 65,256 | | | $ | 44,906 | | | $ | (17,827) | | | $ | 128,141 | |
Other comprehensive gains (losses), net of tax: | | | | | | | |
Foreign currency translation adjustments (Note 6) | (18,771) | | | (32,361) | | | (2,538) | | | (58,075) | |
Pension and post-retirement plan actuarial gains, net of tax (Note 6) | 188 | | | 2,299 | | | 742 | | | 6,893 | |
Unrealized gain (loss) on available-for-sale securities (Note 6) | — | | | 13 | | | 2 | | | (5) | |
Reclassifications of currency translation from accumulated other comprehensive loss into net income (Note 6) | 101 | | | 2,912 | | | 101 | | | 2,912 | |
Total other comprehensive loss, net of tax | (18,482) | | | (27,137) | | | (1,693) | | | (48,275) | |
Comprehensive income (loss) | $ | 46,774 | | | $ | 17,769 | | | $ | (19,520) | | | $ | 79,866 | |
| | | | | | | |
| | | | | | | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
Unaudited
| | | | | | | | | | | | | | |
(In thousands) | | September 30, 2023 | | December 31, 2022 |
Assets | | | | |
Cash and cash equivalents | | $ | 164,499 | | | $ | 162,902 | |
Trade receivables, less allowance for credit loss of $7,262 and $6,769 | | 294,907 | | | 297,028 | |
Inventories (Note 4) | | 324,077 | | | 338,316 | |
Investments, short-term (Note 16) | | — | | | 9,905 | |
Prepaid income taxes | | 29,379 | | | 21,700 | |
Notes receivable, insurance companies (Note 17) | | — | | | 5,931 | |
Prepaid expenses and other current assets | | 38,957 | | | 44,344 | |
Total current assets | | 851,819 | | | 880,126 | |
| | | | |
Property, plant and equipment, net (Note 5) | | 205,650 | | | 207,552 | |
Operating lease right-of-use assets, net | | 49,125 | | | 44,142 | |
Prepaid pension cost (Note 14) | | 151,400 | | | 141,643 | |
Deferred tax assets (Note 10) | | 25,966 | | | 25,490 | |
Goodwill (Note 13) | | 620,343 | | | 620,622 | |
Intangible assets, net (Note 13) | | 268,321 | | | 281,853 | |
Notes receivable, insurance companies (Note 17) | | — | | | 38,695 | |
| | | | |
Insurance receivables (Note 17) and other noncurrent assets | | 21,711 | | | 136,853 | |
Total assets | | $ | 2,194,335 | | | $ | 2,376,976 | |
| | | | |
Liabilities | | | | |
Notes payable and current portion of long-term debt (Note 12) | | $ | 26,198 | | | $ | 7,387 | |
Accounts payable | | 108,554 | | | 112,532 | |
Employees’ compensation | | 58,821 | | | 45,077 | |
Insurance and product liability (Note 17) | | 9,551 | | | 73,898 | |
Income taxes payable (Note 10) | | 28,205 | | | 6,149 | |
Accrued restructuring (Note 3) and other current liabilities | | 94,072 | | | 100,822 | |
Total current liabilities | | 325,401 | | | 345,865 | |
| | | | |
Long-term debt, net (Note 12) | | 715,814 | | | 565,445 | |
Pensions and other employee benefits (Note 14) | | 137,563 | | | 137,810 | |
Noncurrent operating lease liabilities | | 40,913 | | | 35,345 | |
Deferred tax liabilities (Note 10) | | 102,155 | | | 31,881 | |
Product liability (Note 17) and other noncurrent liabilities | | 3,763 | | | 336,889 | |
Total liabilities | | $ | 1,325,609 | | | $ | 1,453,235 | |
| | | | |
Equity | | | | |
Preferred stock, 4.5% cumulative, $50 par value (Note 7) | | $ | 3,569 | | | $ | 3,569 | |
Common stock, no par value (Note 7) | | 303,417 | | | 281,980 | |
Treasury shares, at cost (Note 7) | | (363,371) | | | (361,438) | |
Accumulated other comprehensive loss (Note 6) | | (160,410) | | | (158,717) | |
Retained earnings | | 1,085,521 | | | 1,158,347 | |
| | | | |
| | | | |
Total shareholders’ equity | | 868,726 | | | 923,741 | |
Total liabilities and shareholders’ equity | | $ | 2,194,335 | | | $ | 2,376,976 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited
| | | | | | | | | | | |
| Nine Months Ended September 30, |
(In thousands) | 2023 | | 2022 |
Operating Activities | | | |
Net (loss) income | $ | (17,827) | | | $ | 128,141 | |
Depreciation and amortization | 44,965 | | | 41,883 | |
| | | |
Tax-effected loss on divestiture of MSA LLC (Note 17) | 199,578 | | | — | |
Stock-based compensation (Note 11) | 21,506 | | | 11,325 | |
Pension income (Note 14) | (6,060) | | | (7,956) | |
Deferred income tax benefit (Note 10) | (531) | | | (2,451) | |
(Gain) loss on asset dispositions, net | (671) | | | 4,776 | |
Pension contributions (Note 14) | (4,274) | | | (5,743) | |
Currency exchange losses, net | 8,781 | | | 4,788 | |
Product liability expense (Note 17) | 3 | | | 9,733 | |
Collections on insurance receivables and notes receivable, insurance companies (Note 17) | — | | | 9,510 | |
Product liability payments (Note 17) | (5,250) | | | (9,076) | |
Contribution on divestiture of MSA LLC (Note 17) | (341,186) | | | — | |
| | | |
Changes in: | | | |
Trade receivables | (7,449) | | | 1,958 | |
Inventories (Note 4) | 15,386 | | | (86,599) | |
Accounts payable | (4,225) | | | 2,629 | |
Other current assets and liabilities | 26,518 | | | 270 | |
Other noncurrent assets and liabilities | 4,679 | | | 715 | |
Cash Flow (Used in) From Operating Activities | (66,057) | | | 103,903 | |
Investing Activities | | | |
Capital expenditures | (30,979) | | | (28,753) | |
Proceeds from maturities of short-term investments (Note 16) | — | | | 94,000 | |
Purchase of short-term investments (Note 16) | — | | | (69,680) | |
Property disposals and other investing | 2,690 | | | 38 | |
| | | |
Cash Flow Used in Investing Activities | (28,289) | | | (4,395) | |
Financing Activities | | | |
| | | |
Proceeds from long-term debt (Note 12) | 1,507,000 | | | 798,000 | |
Payments on long-term debt (Note 12) | (1,338,352) | | | (771,000) | |
Debt issuance costs | (1,138) | | | — | |
Cash dividends paid | (54,999) | | | (53,447) | |
Company stock purchases (Note 7) | (3,941) | | | (34,365) | |
Exercise of stock options (Note 7) | 1,440 | | | 4,163 | |
Employee stock purchase plan (Note 7) | 497 | | | 486 | |
| | | |
| | | |
| | | |
Cash Flow From (Used in) Financing Activities | 110,507 | | | (56,163) | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (14,152) | | | (23,498) | |
Increase in cash, cash equivalents and restricted cash | 2,009 | | | 19,847 | |
Beginning cash, cash equivalents and restricted cash | 164,428 | | | 141,438 | |
Ending cash, cash equivalents and restricted cash | $ | 166,437 | | | $ | 161,285 | |
| | | |
Supplemental cash flow information: | | | |
Cash and cash equivalents | $ | 164,499 | | | $ | 159,613 | |
Restricted cash included in prepaid expenses and other current assets | 1,938 | | | 1,672 | |
Total cash, cash equivalents and restricted cash | $ | 166,437 | | | $ | 161,285 | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN RETAINED EARNINGS
AND ACCUMULATED OTHER COMPREHENSIVE LOSS
Unaudited
| | | | | | | | | | | | | |
(In thousands, except per share values) | Retained Earnings | | Accumulated Other Comprehensive (Loss) | | |
Balances June 30, 2022 | $ | 1,098,048 | | | $ | (170,278) | | | |
Net income | 44,906 | | | — | | | |
Foreign currency translation adjustments | — | | | (32,361) | | | |
Pension and post-retirement plan adjustments, net of tax benefit of $981 | — | | | 2,299 | | | |
Unrealized net losses on available-for-sale securities (Note 16) | — | | | 13 | | | |
| | | | | |
Reclassification from accumulated other comprehensive loss into net income | — | | | 2,912 | | | |
| | | | | |
Common dividends ($0.46 per share) | (18,036) | | | — | | | |
Preferred dividends ($0.5625 per share) | (10) | | | — | | | |
Balances September 30, 2022 | $ | 1,124,908 | | | $ | (197,415) | | | |
| | | | | |
Balances June 30, 2023 | $ | 1,038,750 | | | $ | (141,928) | | | |
Net income | 65,256 | | | — | | | |
Foreign currency translation adjustments | — | | | (18,771) | | | |
Pension and post-retirement plan adjustments, net of tax expense of $27 | — | | | 188 | | | |
| | | | | |
Reclassification from accumulated other comprehensive loss into net income (Note 6) | — | | | 101 | | | |
| | | | | |
| | | | | |
| | | | | |
Common dividends ($0.47 per share) | (18,475) | | | — | | | |
Preferred dividends ($0.5625 per share) | (10) | | | — | | | |
Balances September 30, 2023 | $ | 1,085,521 | | | $ | (160,410) | | | |
| | | | | |
Balances December 31, 2021 | $ | 1,050,214 | | | $ | (149,140) | | | |
Net income | 128,141 | | | — | | | |
Foreign currency translation adjustments | — | | | (58,075) | | | |
Pension and post-retirement plan adjustments, net of tax benefit of $2,947 | — | | | 6,893 | | | |
Unrecognized net losses on available-for-sale securities (Note 16) | — | | | (5) | | | |
Reclassification from accumulated other comprehensive loss into net income (Note 6) | — | | | 2,912 | | | |
| | | | | |
| | | | | |
| | | | | |
Common dividends ($1.36 per share) | (53,417) | | | — | | | |
Preferred dividends ($1.6875 per share) | (30) | | | — | | | |
| | | | | |
Balances September 30, 2022 | $ | 1,124,908 | | | $ | (197,415) | | | |
| | | | | |
Balances December 31, 2022 | $ | 1,158,347 | | | $ | (158,717) | | | |
Net loss | (17,827) | | | — | | | |
Foreign currency translation adjustments | — | | | (2,538) | | | |
Pension and post-retirement plan adjustments, net of tax expense of $259 | — | | | 742 | | | |
Unrecognized net gains on available-for-sale securities (Note 16) | — | | | 2 | | | |
Reclassification from accumulated other comprehensive loss into net income (Note 6) | — | | | 101 | | | |
| | | | | |
| | | | | |
| | | | | |
Common dividends ($1.40 per share) | (54,969) | | | — | | | |
Preferred dividends ($1.6875 per share) | (30) | | | — | | | |
| | | | | |
Balances September 30, 2023 | $ | 1,085,521 | | | $ | (160,410) | | | |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
MSA SAFETY INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
Note 1—Basis of Presentation
The condensed consolidated financial statements of MSA Safety Incorporated and its subsidiaries ("MSA" or "the Company") are unaudited. These unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the Company's results. Intercompany accounts and transactions have been eliminated. The results reported in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. The December 31, 2022, Balance Sheet data was derived from the audited Consolidated Balance Sheets, but does not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP"). This Form 10-Q report should be read in conjunction with MSA's Form 10-K for the year ended December 31, 2022, which includes all disclosures required by U.S. GAAP.
Note 2—Cash and Cash Equivalents
Several of the Company's subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in Cash and cash equivalents in the unaudited Condensed Consolidated Balance Sheets.
The Company's net cash pool position consisted of the following:
| | | | | | | | |
(In thousands) | | September 30, 2023 |
Gross cash pool position | | $ | 103,618 | |
Less: cash pool borrowings | | 95,416 | |
Net cash pool position | | $ | 8,202 | |
Note 3—Restructuring Charges
During the three and nine months ended September 30, 2023, we recorded restructuring charges of $3.3 million and $8.4 million, respectively. Americas segment restructuring charges of $2.7 million during the nine months ended September 30, 2023, were related to manufacturing footprint optimization activities. International segment restructuring charges of $3.6 million during the nine months ended September 30, 2023, were related to ongoing initiatives to drive profitable growth and improve productivity. Corporate segment restructuring charges of $2.1 million during the nine months ended September 30, 2023, were related to footprint optimization activities and management restructuring.
During the three and nine months ended September 30, 2022, we recorded restructuring charges of $0.9 million and $3.1 million, respectively. International segment restructuring charges of $2.2 million during the nine months ended September 30, 2022, were primarily related to the implementation of our European Shared Service Center in Warsaw, Poland. Americas segment restructuring charges of $1.0 million during the nine months ended September 30, 2022, were primarily related to various optimization activities.
Restructuring reserves are included in Accrued restructuring and other current liabilities in the accompanying unaudited Condensed Consolidated Balance Sheets. Activity and reserve balances for restructuring by segment were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
(In millions) | Americas | | International | | Corporate | | Total |
Reserve balances at December 31, 2021 | $ | 3.3 | | | $ | 17.4 | | | $ | 0.3 | | | $ | 21.0 | |
Restructuring charges | 2.3 | | | 5.1 | | | 0.6 | | | 8.0 | |
Currency translation | 0.1 | | | (1.3) | | | — | | | (1.2) | |
Cash payments / utilization | (4.0) | | | (8.4) | | | (0.4) | | | (12.8) | |
Reserve balances at December 31, 2022 | $ | 1.7 | | | $ | 12.8 | | | $ | 0.5 | | | $ | 15.0 | |
Restructuring charges | 2.7 | | | 3.6 | | | 2.1 | | | 8.4 | |
Currency translation | (0.2) | | | (0.2) | | | — | | | (0.4) | |
Cash payments | (3.2) | | | (6.5) | | | (2.3) | | | (12.0) | |
Reserve balances at September 30, 2023 | $ | 1.0 | | | $ | 9.7 | | | $ | 0.3 | | | $ | 11.0 | |
Note 4—Inventories
The following table sets forth the components of inventory:
| | | | | | | | | | | | | | |
(In thousands) | | September 30, 2023 | | December 31, 2022 |
Finished products | | $ | 99,588 | | | $ | 97,142 | |
Work in process | | 22,904 | | | 16,360 | |
Raw materials and supplies | | 201,585 | | | 224,814 | |
Total inventories | | $ | 324,077 | | | $ | 338,316 | |
Note 5—Property, Plant and Equipment
The following table sets forth the components of property, plant and equipment, net:
| | | | | | | | | | | |
(In thousands) | September 30, 2023 | | December 31, 2022 |
Land | $ | 4,253 | | | $ | 4,884 | |
| | | |
Buildings | 135,544 | | | 138,618 | |
Machinery and equipment | 481,614 | | | 466,394 | |
Construction in progress | 26,202 | | | 22,097 | |
Total | 647,613 | | | 631,993 | |
Less: accumulated depreciation | (441,963) | | | (424,441) | |
Property, plant and equipment, net | $ | 205,650 | | | $ | 207,552 | |
Note 6—Reclassifications Out of Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, | | Nine Months Ended September 30, |
(In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
Pension and other post-retirement benefits (a) | | | | | | | |
Balance at beginning of period | $ | (49,781) | | | $ | (52,702) | | | $ | (50,335) | | | $ | (57,296) | |
Amounts reclassified from accumulated other comprehensive loss into net income (loss): | | | | | | | |
Amortization of prior service credit (Note 14) | (24) | | | (48) | | | (72) | | | (144) | |
Recognized net actuarial losses (Note 14) | 185 | | | 3,328 | | | 555 | | | 9,984 | |
Tax expense (benefit) | 27 | | | (981) | | | 259 | | | (2,947) | |
Total amount reclassified from accumulated other comprehensive loss, net of tax, into net income (loss) | 188 | | | 2,299 | | | 742 | | | 6,893 | |
| | | | | | | |
Balance at end of period | $ | (49,593) | | | $ | (50,403) | | | $ | (49,593) | | | $ | (50,403) | |
Available-for-sale securities | | | | | | | |
Balance at beginning of period | $ | — | | | $ | (23) | | | $ | (2) | | | $ | (5) | |
Unrealized net gains (losses) on available-for-sale securities (Note 16) | — | | | 13 | | | 2 | | | (5) | |
Balance at end of period | $ | — | | | $ | (10) | | | $ | — | | | $ | (10) | |
Foreign currency translation | | | | | | | |
Balance at beginning of period | $ | (92,147) | | | $ | (117,553) | | | $ | (108,380) | | | $ | (91,839) | |
Reclassification from accumulated other comprehensive loss into net income (loss)(b) | 101 | | | 2,912 | | | 101 | | | 2,912 | |
| | | | | | | |
Foreign currency translation adjustments | (18,771) | | | (32,361) | | | (2,538) | | | (58,075) | |
Balance at end of period | $ | (110,817) | | | $ | (147,002) | | | $ | (110,817) | | | $ | (147,002) | |
(a) Reclassifications out of accumulated other comprehensive loss and into net income (loss) are included in the computation of net periodic pension and other post-retirement benefit costs (refer to Note 14—Pensions and Other Post-retirement Benefits). (b) Reclassifications out of accumulated other comprehensive loss and into net income (loss) relate primarily to the approval of our plan to close a foreign subsidiary. |
Note 7—Capital Stock
Preferred Stock - The Company has authorized 100,000 shares of $50 par value 4.5% cumulative preferred nonvoting stock which is callable at $52.50. There were 71,340 shares issued and 52,998 shares held in treasury at both September 30, 2023 and December 31, 2022. The Treasury shares at cost line in the unaudited Condensed Consolidated Balance Sheets includes $1.8 million related to preferred stock. There were no shares of preferred stock purchased and subsequently held in treasury during the nine months ended September 30, 2023 or 2022. The Company has also authorized 1,000,000 shares of $10 par value second cumulative preferred voting stock. No shares have been issued as of September 30, 2023.
Common Stock - The Company has authorized 180,000,000 shares of no par value common stock. There were 62,081,391 shares issued as of September 30, 2023 and December 31, 2022. No new shares were issued during the nine months ended September 30, 2023 or 2022. There were 39,310,511 and 39,213,064 shares outstanding at September 30, 2023 and December 31, 2022, respectively.
Treasury Shares - The Company's stock repurchase program authorizes up to $100.0 million to repurchase MSA common stock in the open market and in private transactions. The stock repurchase program has no expiration date. The maximum number of shares that may be repurchased is calculated based on the dollars remaining under the program and the respective month-end closing share price. During the nine months ended September 30, 2023, no shares were repurchased under this program. During the nine months ended September 30, 2022, 251,408 shares were repurchased under this program. There were 22,770,880 and 22,868,327 treasury shares at September 30, 2023 and December 31, 2022, respectively.
The Company issues treasury shares for all stock-based benefit plans. Shares are issued from treasury at the average treasury share cost on the date of the transaction. There were 125,967 and 203,619 Treasury shares issued for these purposes during the nine months ended September 30, 2023 and 2022, respectively.
Common stock activity is summarized as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended September 30, 2023 | | Three Months Ended September 30, 2022 |
(In thousands) | Common Stock | | Treasury Cost(a) | | Common Stock | | Treasury Cost(a) |
Balance at beginning of period | $ | 294,364 | | | $ | (362,025) | | | $ | 267,645 | | | $ | (359,314) | |
Stock compensation expense | 8,477 | | | — | | | 2,967 | | | — | |
Restricted and performance stock awards | (15) | | | 15 | | | (103) | | | 103 | |
Stock options exercised | 591 | | | 307 | | | 2,501 | | | 1,364 | |
Treasury shares purchased for stock compensation programs | — | | | (70) | | | — | | | (59) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Share repurchase program | — | | | — | | | — | | | (2,150) | |
Balance at end of period | $ | 303,417 | | | $ | (361,773) | | | $ | 273,010 | | | $ | (360,056) | |
(a)Excludes treasury cost related to preferred stock. |
| | | | | | | | | | | | | | | | | | | | | | | |
| Nine Months Ended September 30, 2023 | | Nine Months Ended September 30, 2022 |
(In thousands) | Common Stock | | Treasury Cost(a) | | Common Stock | | Treasury Cost(a) |
Balance at beginning of period | $ | 281,980 | | | $ | (359,838) | | | $ | 260,121 | | | $ | (328,776) | |
Stock compensation expense | 21,506 | | | — | | | 11,325 | | | — | |
Restricted and performance stock awards | (1,449) | | | 1,449 | | | (1,564) | | | 1,564 | |
Stock options exercised | 948 | | | 492 | | | 2,704 | | | 1,459 | |
Treasury shares purchased for stock compensation programs | — | | | (3,941) | | | — | | | (3,990) | |
| | | | | | | |
| | | | | | | |
Employee stock purchase program | 432 | | | 65 | | | 424 | | | 62 | |
Share repurchase program | — | | | — | | | — | | | (30,375) | |
Balance at end of period | $ | 303,417 | | | $ | (361,773) | | | $ | 273,010 | | | $ | (360,056) | |
(a)Excludes treasury cost related to preferred stock. |
Note 8—Segment Information
The Company is organized into four geographical operating segments that are based on management responsibilities: Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The operating segments have been aggregated (based on economic similarities, the nature of their products, end-user markets and methods of distribution) into three reportable segments: Americas, International, and Corporate.
The Americas segment is comprised of our operations in Northern North American and Latin American geographies. The International segment is comprised of our operations in all geographies outside of the Americas. Certain global expenses are allocated to each segment in a manner consistent with where the benefits from the expenses are derived.
The Company's sales are allocated to each segment based primarily on the country destination of the end-customer.
Adjusted operating income (loss), adjusted operating margin, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA margin are the measures used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is defined as operating income (loss) excluding restructuring charges, currency exchange (gains) losses, product liability expense, loss on divestiture of Mine Safety Appliances Company, LLC ("MSA LLC"), transaction costs and acquisition-related amortization. Adjusted operating margin is defined as adjusted operating income (loss) divided by segment net sales to external customers. Adjusted EBITDA is defined as adjusted operating income (loss) plus depreciation and amortization. Adjusted EBITDA margin is defined as adjusted EBITDA divided by segment net sales to external customers.
The accounting principles applied at the operating segment level in determining operating income (loss) are generally the same as those applied at the unaudited condensed consolidated financial statement level. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation.
Reportable segment information is presented in the following table: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands, except percentages) | | Americas | | International | | Corporate | | | | Consolidated Totals |
Three Months Ended September 30, 2023 | | | | | | | | | | |
Net sales to external customers | | $ | 314,273 | | | $ | 132,455 | | | $ | — | | | | | $ | 446,728 | |
| | | | | | | | | | |
Operating income | | | | | | | | | | 94,123 | |
Restructuring charges (Note 3) | | | | | | | | | | 3,285 | |
Currency exchange losses, net | | | | | | | | | | 1,496 | |
| | | | | | | | | | |
| | | | | | | | | | |
Amortization of acquisition-related intangible assets | | | | | | | | | | 2,315 | |
Transaction costs(a) | | | | | | | | | | 78 | |
| | | | | | | | | | |
Adjusted operating income (loss) | | 93,918 | | | 22,577 | | | (15,198) | | | | | 101,297 | |
Adjusted operating margin % | | 29.9 | % | | 17.0 | % | | | | | | |
Depreciation and amortization | | | | | | | | | | 13,189 | |
Adjusted EBITDA | | 103,157 | | | 26,289 | | | (14,960) | | | | | 114,486 | |
Adjusted EBITDA margin % | | 32.8 | % | | 19.8 | % | | | | | | |
| | | | | | | | | | |
Three Months Ended September 30, 2022 | | | | | | | | | | |
Net sales to external customers | | $ | 276,082 | | | $ | 105,612 | | | $ | — | | | | | $ | 381,694 | |
| | | | | | | | | | |
Operating income | | | | | | | | | | 64,313 | |
Restructuring charges (Note 3) | | | | | | | | | | 899 | |
Currency exchange losses, net | | | | | | | | | | 2,979 | |
Product liability expense (Note 17) | | | | | | | | | | 4,035 | |
Amortization of acquisition-related intangible assets | | | | | | | | | | 2,279 | |
Transaction costs(a) | | | | | | | | | | 620 | |
| | | | | | | | | | |
Adjusted operating income (loss) | | 75,088 | | | 8,448 | | | (8,411) | | | | | 75,125 | |
Adjusted operating margin % | | 27.2 | % | | 8.0 | % | | | | | | |
Depreciation and amortization | | | | | | | | | | 11,518 | |
Adjusted EBITDA | | 83,945 | | | 10,980 | | | (8,282) | | | | | 86,643 | |
Adjusted EBITDA margin % | | 30.4 | % | | 10.4 | % | | | | | | |
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations. |
| | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(In thousands, except percentages) | | Americas | | International | | Corporate | | | | Consolidated Totals |
Nine Months Ended September 30, 2023 | | | | | | | | | | |
Net sales to external customers | | $ | 902,918 | | | $ | 389,372 | | | $ | — | | | | | $ | 1,292,290 | |
| | | | | | | | | | |
Operating income | | | | | | | | | | 129,070 | |
Restructuring charges (Note 3) | | | | | | | | | | 8,382 | |
Currency exchange losses, net | | | | | | | | | | 8,781 | |
Loss on divestiture of MSA LLC (Note 17) | | | | | | | | | | 129,211 | |
Product liability expense (Note 17) | | | | | | | | | | 3 | |
Amortization of acquisition-related intangible assets | | | | | | | | | | 6,936 | |
Transaction costs(a) | | | | | | | | | | 78 | |
| | | | | | | | | | |
Adjusted operating income (loss) | | 260,428 | | | 60,099 | | | (38,066) | | | | | 282,461 | |
Adjusted operating margin % | | 28.8 | % | | 15.4 | % | | | | | | |
Depreciation and amortization | | | | | | | | | | 38,029 | |
Adjusted EBITDA | | 287,628 | | | 70,296 | | | (37,434) | | | | | 320,490 | |
Adjusted EBITDA margin % | | 31.9 | % | | 18.1 | % | | | | | | |
| | | | | | | | | | |
Nine Months Ended September 30, 2022 | | | | | | | | | | |
Net sales to external customers | | $ | 754,116 | | | $ | 330,583 | | | $ | — | | | | | $ | 1,084,699 | |
| | | | | | | | | | |
Operating income | | | | | | | | | | 168,517 | |
Restructuring charges (Note 3) | | | | | | | | | | 3,146 | |
Currency exchange losses, net | | | | | | | | | | 4,788 | |
Product liability expense (Note 17) | | | | | | | | | | 9,733 | |
Amortization of acquisition-related intangible assets | | | | | | | | | | 6,922 | |
Transaction costs(a) | | | | | | | | | | 1,476 | |
| | | | | | | | | | |
Adjusted operating income (loss) | | 184,664 | | | 34,674 | | | (24,756) | | | | | 194,582 | |
Adjusted operating margin % | | 24.5 | % | | 10.5 | % | | | | | | |
Depreciation and amortization | | | | | | | | | | 34,961 | |
Adjusted EBITDA | | 210,201 | | | 43,708 | | | (24,366) | | | | | 229,543 | |
Adjusted EBITDA margin % | | 27.9 | % | | 13.2 | % | | | | | | |
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations. |
| | | | | | | | | | |
Total sales by product group was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Three Months Ended September 30, 2023 | Consolidated | | Americas | | International |
(In thousands, except percentages) | Dollars | Percent | | Dollars | Percent | | Dollars | Percent |
Fixed Gas & Flame Detection | $ | 112,012 | | 25% | | $ | 73,074 | | 23% | | $ | 38,938 | | 29% |
Breathing Apparatus | 111,024 | | 25% | | 79,908 | | 25% | | 31,116 | | 24% |
Firefighter Helmets & Protective Apparel | 64,707 | | 15% | | 51,608 | | 16% | | 13,099 | | 10% |
Portable Gas Detection | 43,682 | | 10% | | 31,933 | | 10% | | 11,749 | | 9% |
Industrial Head Protection | 45,780 | | 10% | | 36,402 | | 12% | | 9,378 | | 7% |
Fall Protection | 31,980 | | 7% | | 20,235 | | 7% | | 11,745 | | 9% |
Other | 37,543 | | 8% | | 21,113 | | 7% | | 16,430 | | 12% |
Total | $ | 446,728 | | 100% | | $ | 314,273 | | 100% | | $ | 132,455 | | 100% |
| | | | | | | | |
Three Months Ended September 30, 2022 | Consolidated | | Americas | | International |
(In thousands, except percentages) | Dollars | Percent | | Dollars | Percent | | Dollars | Percent |
Fixed Gas & Flame Detection | $ | 87,746 | | 23% | | $ | 62,134 | | 23% | | $ | 25,612 | | 24% |
Breathing Apparatus | 91,977 | | 24% | | 70,482 | | 26% | | 21,495 | | 20% |
Firefighter Helmets & Protective Apparel | 54,738 | | 14% | | 41,958 | | 15% | | 12,780 | | 12% |
Portable Gas Detection | 39,481 | | 10% | | 28,358 | | 10% | | 11,123 | | 11% |
Industrial Head Protection | 43,608 | | 11% | | 34,620 | | 13% | | 8,988 | | 9% |
Fall Protection | 27,839 | | 7% | | 17,658 | | 6% | | 10,181 | | 10% |
Other | 36,305 | | 11% | | 20,872 | | 7% | | 15,433 | | 14% |
Total | $ | 381,694 | | 100% | | $ | 276,082 | | 100% | | $ | 105,612 | | 100% |
| | | | | | | | |
Nine Months Ended September 30, 2023 | Consolidated | | Americas | | International |
(In thousands, except percentages) | Dollars | Percent | | Dollars | Percent | | Dollars | Percent |
Fixed Gas & Flame Detection | $ | 311,502 | | 24% | | $ | 200,604 | | 22% | | $ | 110,898 | | 28% |
Breathing Apparatus | 288,976 | | 22% | | 201,945 | | 22% | | 87,031 | | 22% |
Firefighter Helmets & Protective Apparel | 192,634 | | 15% | | 152,784 | | 17% | | 39,850 | | 10% |
Portable Gas Detection | 149,036 | | 12% | | 108,088 | | 12% | | 40,948 | | 11% |
Industrial Head Protection | 135,851 | | 11% | | 106,120 | | 12% | | 29,731 | | 8% |
Fall Protection | 97,019 | | 7% | | 63,168 | | 7% | | 33,851 | | 9% |
Other | 117,272 | | 9% | | 70,209 | | 8% | | 47,063 | | 12% |
Total | $ | 1,292,290 | | 100% | | $ | 902,918 | | 100% | | $ | 389,372 | | 100% |
| | | | | | | | |
Nine Months Ended September 30, 2022 | Consolidated | | Americas | | International |
(In thousands, except percentages) | Dollars | Percent | | Dollars | Percent | | Dollars | Percent |
Fixed Gas & Flame Detection | $ | 251,321 | | 23% | | $ | 167,269 | | 22% | | $ | 84,052 | | 25% |
Breathing Apparatus | 254,878 | | 23% | | 185,490 | | 25% | | 69,388 | | 21% |
Firefighter Helmets & Protective Apparel | 151,097 | | 14% | | 110,471 | | 15% | | 40,626 | | 12% |
Portable Gas Detection | 121,116 | | 11% | | 85,815 | | 11% | | 35,301 | | 11% |
Industrial Head Protection | 123,489 | | 11% | | 96,808 | | 13% | | 26,681 | | 8% |
Fall Protection | 79,114 | | 7% | | 50,940 | | 7% | | 28,174 | | 9% |
Other | 103,684 | | 11% | | 57,323 | | 7% | | 46,361 | | 14% |
Total | $ | 1,084,699 | | 100% | | $ | 754,116 | | 100% | | $ | 330,583 | | 100% |
Note 9—Earnings (Loss) per Share
Basic earnings (loss) per share is computed by dividing net income, after the deduction of preferred stock dividends and undistributed earnings allocated to participating securities, by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share assumes the issuance of common stock for all potentially dilutive share equivalents outstanding not classified as participating securities. Participating securities are defined as unvested stock-based compensation awards that contain nonforfeitable rights to dividends.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended September 30, | | Nine Months Ended September 30, |
(In thousands, except per share values) | | 2023 | | 2022 | | 2023 | | 2022 |
Net income (loss) | | $ | 65,256 | | | $ | 44,906 | | | $ | (17,827) | | | $ | 128,141 | |
Preferred stock dividends | | (10) | | | (10) | | | (30) | | | (30) | |
Net income (loss) attributable to common equity | | 65,246 | | | 44,896 | | | (17,857) | | | 128,111 | |
Dividends and undistributed earnings allocated to participating securities | | (8) | | | (8) | | | (16) | | | (21) | |
Net income (loss) attributable to common shareholders | | 65,238 | | | 44,888 | | | (17,873) | | | 128,090 | |
| | | | | | | | |
Basic weighted-average shares outstanding | | 39,303 | | | 39,172 | | | 39,267 | | | 39,243 | |
Stock-based compensation awards (a) | | 147 | | | 127 | | | — | | | 171 | |
Diluted weighted-average shares outstanding | | 39,450 | | | 39,299 | | | 39,267 | | | 39,414 | |
Antidilutive shares | | — | | | — | | | 154 | | | — | |
| | | | | | | | |
Earnings (loss) per share: | | | | | | | | |
Basic | | $ | 1.66 | | | $ | 1.15 | | | $ | (0.46) | | | $ | |